247 related articles for article (PubMed ID: 11208881)
41. Time trends and occupational variation in the incidence of testicular cancer in the Nordic countries.
Ylönen O; Jyrkkiö S; Pukkala E; Syvänen K; Boström PJ
BJU Int; 2018 Sep; 122(3):384-393. PubMed ID: 29460991
[TBL] [Abstract][Full Text] [Related]
42. Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920-2000.
Tryggvadottir L; Sigvaldason H; Olafsdottir GH; Jonasson JG; Jonsson T; Tulinius H; Eyfjörd JE
J Natl Cancer Inst; 2006 Jan; 98(2):116-22. PubMed ID: 16418514
[TBL] [Abstract][Full Text] [Related]
43. Cancer Risk in Relatives of Testicular Cancer Patients by Histology Type and Age at Diagnosis: A Joint Study from Five Nordic Countries.
Kharazmi E; Hemminki K; Pukkala E; Sundquist K; Tryggvadottir L; Tretli S; Olsen JH; Fallah M
Eur Urol; 2015 Aug; 68(2):283-9. PubMed ID: 25913387
[TBL] [Abstract][Full Text] [Related]
44. High incidence of cancer in a family segregating a mutation of the ATM gene: possible role of ATM heterozygosity in cancer.
Bay JO; Uhrhammer N; Pernin D; Presneau N; Tchirkov A; Vuillaume M; Laplace V; Grancho M; Verrelle P; Hall J; Bignon YJ
Hum Mutat; 1999; 14(6):485-92. PubMed ID: 10571946
[TBL] [Abstract][Full Text] [Related]
45. ATM, radiation, and the risk of second primary breast cancer.
Bernstein JL; ; Concannon P
Int J Radiat Biol; 2017 Oct; 93(10):1121-1127. PubMed ID: 28627265
[TBL] [Abstract][Full Text] [Related]
46. Contribution of mutations in ATM to breast cancer development in the Czech population.
Soukupova J; Dundr P; Kleibl Z; Pohlreich P
Oncol Rep; 2008 Jun; 19(6):1505-10. PubMed ID: 18497957
[TBL] [Abstract][Full Text] [Related]
47. Risk of breast cancer and other cancers in heterozygotes for ataxia-telangiectasia.
Inskip HM; Kinlen LJ; Taylor AM; Woods CG; Arlett CF
Br J Cancer; 1999 Mar; 79(7-8):1304-7. PubMed ID: 10098776
[TBL] [Abstract][Full Text] [Related]
48. Cancer risk in close relatives of women with early-onset breast cancer--a population-based incidence study.
Olsen JH; Seersholm N; Boice JD; Krüger Kjaer S; Fraumeni JF
Br J Cancer; 1999 Feb; 79(3-4):673-9. PubMed ID: 10027348
[TBL] [Abstract][Full Text] [Related]
49. Mortality rates among carriers of ataxia-telangiectasia mutant alleles.
Su Y; Swift M
Ann Intern Med; 2000 Nov; 133(10):770-8. PubMed ID: 11085839
[TBL] [Abstract][Full Text] [Related]
50. Ataxia telangiectasia gene mutations in leukaemia and lymphoma.
Boultwood J
J Clin Pathol; 2001 Jul; 54(7):512-6. PubMed ID: 11429421
[TBL] [Abstract][Full Text] [Related]
51. Cancer Incidence in First- and Second-Degree Relatives of BRCA1 and BRCA2 Mutation Carriers.
Streff H; Profato J; Ye Y; Nebgen D; Peterson SK; Singletary C; Arun BK; Litton JK
Oncologist; 2016 Jul; 21(7):869-74. PubMed ID: 27306910
[TBL] [Abstract][Full Text] [Related]
52. Cancer risk in ATM heterozygotes: a model of phenotypic and mechanistic differences between missense and truncating mutations.
Gatti RA; Tward A; Concannon P
Mol Genet Metab; 1999 Dec; 68(4):419-23. PubMed ID: 10607471
[TBL] [Abstract][Full Text] [Related]
53. Ataxia-telangiectasia gene (
Jerzak KJ; Mancuso T; Eisen A
Curr Oncol; 2018 Apr; 25(2):e176-e180. PubMed ID: 29719442
[TBL] [Abstract][Full Text] [Related]
54. Genetic aspects of ataxia-telangiectasia.
Swift M
Immunodefic Rev; 1990; 2(1):67-81. PubMed ID: 2196911
[TBL] [Abstract][Full Text] [Related]
55. Penetrance of ATM Gene Mutations in Breast Cancer: A Meta-Analysis of Different Measures of Risk.
Marabelli M; Cheng SC; Parmigiani G
Genet Epidemiol; 2016 Jul; 40(5):425-31. PubMed ID: 27112364
[TBL] [Abstract][Full Text] [Related]
56. Phenocopy breast cancer rates in Israeli BRCA1 BRCA2 mutation carrier families: is the risk increased in non-carriers?
Bernholtz S; Laitman Y; Kaufman B; Shimon-Paluch S; Friedman E
Breast Cancer Res Treat; 2012 Apr; 132(2):669-73. PubMed ID: 22113258
[TBL] [Abstract][Full Text] [Related]
57. Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia.
Stankovic T; Weber P; Stewart G; Bedenham T; Murray J; Byrd PJ; Moss PA; Taylor AM
Lancet; 1999 Jan; 353(9146):26-9. PubMed ID: 10023947
[TBL] [Abstract][Full Text] [Related]
58. Occupation and cancer - follow-up of 15 million people in five Nordic countries.
Pukkala E; Martinsen JI; Lynge E; Gunnarsdottir HK; Sparén P; Tryggvadottir L; Weiderpass E; Kjaerheim K
Acta Oncol; 2009; 48(5):646-790. PubMed ID: 19925375
[TBL] [Abstract][Full Text] [Related]
59. ATM Variants in Breast Cancer: Implications for Breast Radiation Therapy Treatment Recommendations.
McDuff SGR; Bellon JR; Shannon KM; Gadd MA; Dunn S; Rosenstein BS; Ho AY
Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1373-1382. PubMed ID: 33545302
[TBL] [Abstract][Full Text] [Related]
60. Cancer risk and the ATM gene: a continuing debate.
Khanna KK
J Natl Cancer Inst; 2000 May; 92(10):795-802. PubMed ID: 10814674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
